Skip to main content
OpenTrials

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

161 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Completed

An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)

NCT07076446

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Research Solutions of AZ Litchfield Park, Arizona, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • Immunoe Health Centers Centennial, Colorado, United States
  • Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
View Trial Details
Completed

Study of PlasmaCap IG in Adults and Children With PIDD

NCT03238079

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • University of California Los Angeles, California, United States
  • IMMUNOe Health & Research Centers Centennial, Colorado, United States
  • University of South Florida Tampa, Florida, United States
  • Allergy Associates of the Palm Beaches, P.A. West Palm Beach, Florida, United States
View Trial Details
Completed

A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants

NCT05513586

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Hospital of University of Occupational and Environmental Health Kitakyushu, Fukuoka, Japan
  • Kanagawa Children's Medical Center Yokohama, Kanagawa, Japan
  • Tokyo Medical Dental University Hospital Bunkyo-ku, Tokyo, Japan
View Trial Details
Completed

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients

NCT03961009

Conditions
Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Dr. Henry J. Kanarek - Allergy, Asthma & Immunology Overland Park, Kansas, United States
  • Midwest Immunology Clinic and Infusion Center Plymouth, Minnesota, United States
View Trial Details

Related conditions